GEODE CAPITAL MANAGEMENT, LLC - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 83 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,517,627
-18.5%
975,572
+2.3%
0.00%0.0%
Q2 2023$7,997,770
+64.9%
953,250
+95.2%
0.00%0.0%
Q1 2023$4,849,269
+149246.1%
488,345
+4.7%
0.00%
Q4 2022$3,247
-99.9%
466,577
-0.6%
0.00%
Q3 2022$2,506,000
+29.0%
469,429
-3.6%
0.00%
Q2 2022$1,942,000
-52.1%
486,769
-46.7%
0.00%
-100.0%
Q1 2022$4,057,000
+18.9%
912,868
+7.0%
0.00%
Q4 2021$3,411,000
-56.9%
852,760
-5.5%
0.00%
-100.0%
Q3 2021$7,918,000
-22.2%
901,917
+0.4%
0.00%0.0%
Q2 2021$10,180,000
+115.1%
898,517
+125.5%
0.00%0.0%
Q1 2021$4,733,000
+127.3%
398,437
+31.3%
0.00%
Q4 2020$2,082,000
+4.6%
303,505
+13.0%
0.00%
Q3 2020$1,990,000
+99.2%
268,592
+12.1%
0.00%
Q2 2020$999,000
+21.7%
239,598
-28.0%
0.00%
Q1 2020$821,000
-78.6%
332,754
-49.5%
0.00%
Q4 2019$3,830,000
+138.5%
659,384
+116.4%
0.00%
Q3 2019$1,606,000
-11.9%
304,744
+0.3%
0.00%
Q2 2019$1,822,000
-26.5%
303,789
+10.7%
0.00%
-100.0%
Q1 2019$2,478,000
-39.1%
274,448
-44.1%
0.00%0.0%
Q4 2018$4,072,000
+88.8%
490,784
+213.9%
0.00%0.0%
Q3 2018$2,157,000
+83.7%
156,335
+5.8%
0.00%
Q2 2018$1,174,000
+53.3%
147,737
+44.5%
0.00%
Q1 2018$766,000
+10.2%
102,2630.0%0.00%
Q4 2017$695,000
+27.1%
102,263
+34.6%
0.00%
Q3 2017$547,000
+101.8%
75,994
+31.4%
0.00%
Q2 2017$271,000
-1.1%
57,854
+5.4%
0.00%
Q1 2017$274,000
-3.2%
54,888
+3.6%
0.00%
Q4 2016$283,000
-31.8%
52,9760.0%0.00%
Q3 2016$415,000
+171.2%
52,976
+96.4%
0.00%
Q2 2016$153,000
+56.1%
26,977
+14.5%
0.00%
Q1 2016$98,000
-35.5%
23,558
+4.4%
0.00%
Q4 2015$152,000
+16.0%
22,5580.0%0.00%
Q3 2015$131,000
-25.1%
22,5580.0%0.00%
Q2 2015$175,000
-25.2%
22,5580.0%0.00%
Q1 2015$234,000
+44.4%
22,5580.0%0.00%
Q4 2014$162,000
+20.0%
22,5580.0%0.00%
Q3 2014$135,00022,5580.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders